摘要
No AccessJournal of UrologyAdult Urology1 Jul 2017AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points John T. Stoffel, Andrew C. Peterson, Jaspreet S. Sandhu, Anne M. Suskind, John T. Wei, and Deborah J. Lightner John T. StoffelJohn T. Stoffel University of Michigan, Ann Arbor, Michigan More articles by this author , Andrew C. PetersonAndrew C. Peterson Duke University, Durham, North Carolina Financial and/or other relationship with AMS. More articles by this author , Jaspreet S. SandhuJaspreet S. Sandhu Memorial Sloan Kettering Hospital, New York, New York More articles by this author , Anne M. SuskindAnne M. Suskind University of Calfornia, San Francisco, San Francisco, California More articles by this author , John T. WeiJohn T. Wei University of Michigan, Ann Arbor, Michigan More articles by this author , and Deborah J. LightnerDeborah J. Lightner Mayo Clinic, Rochester, Minnesota More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.01.075AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: The AUA (American Urological Association) QIPS (Quality Improvement and Patient Safety) committee created a white paper on the diagnosis and management of nonneurogenic chronic urinary retention. Materials and Methods: Recommendations for the white paper were based on a review of the literature and consensus expert opinion from the workgroup. Results: The workgroup defined nonneurogenic chronic urinary retention as an elevated post-void residual of greater than 300 mL that persisted for at least 6 months and documented on 2 or more separate occasions. It is proposed that chronic urinary retention should be categorized by risk (high vs low) and symptomatology (symptomatic versus asymptomatic). High risk chronic urinary retention was defined as hydronephrosis on imaging, stage 3 chronic kidney disease or recurrent culture proven urinary tract infection or urosepsis. Symptomatic chronic urinary retention was defined as subjectively moderate to severe urinary symptoms impacting quality of life and/or a recent history of catheterization. A treatment algorithm was developed predicated on stratifying patients with chronic urinary retention first by risk and then by symptoms. The proposed 4 primary outcomes that should be assessed to determine effectiveness of retention treatment are 1) symptom improvement, 2) risk reduction, 3) successful trial of voiding without catheterization, and 4) stability of symptoms and risk over time. Conclusions: Defining and categorizing nonneurogenic chronic urinary retention, creating a treatment algorithm and proposing treatment end points will hopefully spur comparative research that will ultimately lead to a better understanding of this challenging condition. References 1 : Self-care management questionnaire for long-term indwelling urinary catheter users. Neurourol Urodyn2016; 35: 492. Google Scholar 2 : Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments. Comparative Effectiveness Review No. 140. (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-2007-10064-I.) AHRQ Publication No. 14-EHC041-EF. Rockville, Maryland: Agency for Healthcare Research and Quality2014. Available at www.effectivehealthcare.ahrq.gov/reports/final.cfm. Google Scholar 3 : The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn2002; 21: 167. Google Scholar 4 : Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol2014; 65: 389. Google Scholar 5 : The other bladder syndrome: underactive bladder. Rev Urol2013; 15: 11. Google Scholar 6 International Continence Society: Urinary retention. ICS wiki Web page, 2016. Available at http://wiki.ics.org/Urinary+Retention. Accessed March 16, 2016. Google Scholar 7 National Institute for Health and Care Excellence: Lower urinary tract symptoms in men: management. National Institute for Health and Care Excellence web site, 2015. Available at https://www.nice.org.uk/Guidance/CG97. Accessed March 10, 2016. Google Scholar 8 : Management of acute and chronic retention in men. Eur Urol2009; 8: 523. Google Scholar 9 : Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol2008; 180: 47. Link, Google Scholar 10 : Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients. J Neurol Neurosurg Psychiatry2005; 76: 1670. Google Scholar 11 : The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int2004; 93: 745. Google Scholar 12 : Measurement of post-void residual urine. Neurourol Urodyn2016; 35: 55. Google Scholar 13 : Urodynamic findings in chronic retention of urine and their relevance to results of surgery. Br Med J1978; 2: 1258. Google Scholar 14 : Relationship between detrusor function and residual urine in men undergoing prostatectomy. Br J Urol1987; 60: 560. Google Scholar 15 : Relationship between voiding pressures, symptoms and urodynamic findings in 253 men undergoing prostatectomy. Br J Urol1987; 60: 554. Google Scholar 16 : A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. BJU Int2005; 96: 93. Google Scholar 17 : Success rates of patients with poor emptying on clean intermittent catheterization. Can J Urol2014; 21: 7188. Google Scholar 18 The Renal Association: Stage 3 CKD, 2016. Available at http://www.renal.org/information-resources/the-uk-eckd-guide/stage-3-ckd#sthash.UvApXTx9.dpbs. Accessed March 9, 2016. Google Scholar 19 Hickling DR and Nitti V: Recurrent urinary tract infections in healthy premenopausal and postmenopausal women. AUA Update Series 2012; 31: Lesson 10. Google Scholar 20 : The burden of urologic diseases in America. J Urol2005; 173: 1065. Link, Google Scholar 21 : The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol1992; 148: 1549. Link, Google Scholar 22 American Urological Association: Five Things Physicians and Patients Should Question. Available at http://www.auanet.org/practice-resources/patient-safety-and-quality-of-care/choosing-wisely. Accessed March 16, 2016. Google Scholar 23 : Proportion of complications in patients practicing clean intermittent self-catheterization (CISC) vs indwelling catheter. J Pak Med Assoc2006; 56: 401. Google Scholar 24 : Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG2011; 118: 1055. Google Scholar 25 : Patient preferences for clean intermittent catheterisation and transurethral indwelling catheterisation for treatment of abnormal post-void residual bladder volume after vaginal prolapse surgery. BJOG2011; 118: 1324. Google Scholar 26 : Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev2015; : CD004203. Google Scholar 27 : Intermittent versus indwelling urinary catheterization in older female patients. Maturitas2006; 53: 274. Google Scholar 28 : Long-term bladder drainage: suprapubic catheter versus other methods: a scoping review. Neurourol Urodyn2013; 32: 944. Google Scholar 29 : Compliance of the bladder: an attempt to establish normal values. Urology1979; 14: 204. Google Scholar 30 : Impact of frailty on complications in patients undergoing common urological procedures: a study from the American College of Surgeons National Surgical Quality Improvement database. BJU Int2016; 117: 836. Google Scholar © 2017 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byLerner L, McVary K, Barry M, Bixler B, Dahm P, Das A, Gandhi M, Kaplan S, Kohler T, Martin L, Parsons J, Roehrborn C, Stoffel J, Welliver C and Wilt T (2021) Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II—Surgical Evaluation and TreatmentJournal of Urology, VOL. 206, NO. 4, (818-826), Online publication date: 1-Oct-2021.Wein A (2020) Re: Spontaneous Voiding is Surprisingly Recoverable via Outlet Procedure in Men with Underactive Bladder and Documented Detrusor Underactivity on UrodynamicsJournal of Urology, VOL. 204, NO. 6, (1386-1387), Online publication date: 1-Dec-2020. Volume 198Issue 1July 2017Page: 153-160 Advertisement Copyright & Permissions© 2017 by American Urological Association Education and Research, Inc.Keywordstreatment outcomeurinary retentionAcknowledgmentsAUA staff members Jennifer Bertsch, Heddy Hubbard, Suzanne Pope and Victoria Wilder provided assistance with preparation of this white paper.MetricsAuthor Information John T. Stoffel University of Michigan, Ann Arbor, Michigan More articles by this author Andrew C. Peterson Duke University, Durham, North Carolina Financial and/or other relationship with AMS. More articles by this author Jaspreet S. Sandhu Memorial Sloan Kettering Hospital, New York, New York More articles by this author Anne M. Suskind University of Calfornia, San Francisco, San Francisco, California More articles by this author John T. Wei University of Michigan, Ann Arbor, Michigan More articles by this author Deborah J. Lightner Mayo Clinic, Rochester, Minnesota More articles by this author Expand All Advertisement PDF downloadLoading ...